We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

1 hedge funds and large institutions have $1 invested in Genocea Biosciences, Inc. in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MPCA
1
Madison Park Capital Advisors
Washington
$1 – – –

GNCA Hedge Fund Activity: Q3 2024 in Review

1 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q3 2024, worth a combined $1.

Fund positioning in GNCA was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Genocea Biosciences, Inc. (GNCA) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $1 of Genocea Biosciences, Inc. stock for Q3 2024.
  • 0 funds opened new Genocea Biosciences, Inc. positions in Q3 2024 and 0 closed out.

Based on aggregated 13F filings for Q3 2024.